Social isolation is associated with an increased risk of Alzheimer’s disease and dementias
Analysis the data of more than half a million people in the UK and Canada discovers a link between social capital and Alzheimer's disease-related dementia
5 Billion People at Risk of Heart Disease from Trans Fat
GENEVA — Five billion people globally remain unprotected from harmful trans fat, a new status report from the World Health Organization (WHO) has found, increasing their risk of heart disease and…
Social Sport Platform Splink Makes Sports Accessible to Everyone
Splink, a Singapore based company, is a social sports platform that aims to make sports accessible to everyone globally. Splink empowers their users, from finding sports players, to organizing and…
Microneedling Devices: Getting to the Point on Benefits, Risks and Safety | FDA News
Image Being pricked by tiny needles may sound like a strange way to make your skin look better, but that’s the concept behind a skin care technique called microneedling. People…
FDA Advances Data, IT Modernization Efforts with New Office of Digital Transformation | FDA News
For Immediate Release: September 15, 2021 Today, the U.S. Food and Drug Administration announced the reorganization of the agency’s information technology (IT), data management and cybersecurity functions into the new…
5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC | FDA News
Image Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one…
Focusing on Contact Lens Safety | FDA News
Español Approximately 45 million Americans wear contact lenses. In addition to offering flexibility, convenience, and a “no-glasses” appearance, contacts help correct a variety of vision disorders, including nearsightedness, farsightedness, astigmatism, and…
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals | FDA News
For Immediate Release: September 02, 2021 The following quote is attributed to Sally Choe, Ph.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and…